Page 12 - Pfizer

Pfizer raises sales forecast for Covid vaccine by almost a third to $33 bn

The New York drugmaker had previously projected vaccine sales for the year of $26 billion.

Top headlines: Pfizer raises sales forecast; Maruti misses estimates in Q1

Business Standard brings you the top headlines on Wednesday

Pfizer, Astra vaccine antibody levels may decline after 2-3 months: Lancet

Total antibody levels start to wane six weeks after complete immunisation with Pfizer and AstraZeneca vaccines, and can reduce by more than 50 per cent over 10 weeks, according to The Lancet journal

Covid LIVE: Delhi records zero fatality, 2nd time since onset of 2nd wave

The number of people who have recuperated from the disease has surged to 30,503,166, while the case fatality rate stands at 1.34 per cent

US to buy 200 million more doses of Pfizer vaccine, says White House

The federal government is buying 200 million more doses of the Pfizer coronavirus vaccine to prepare for future needs, such as boosters and shots for kids under 12

No domestic vaccine maker has sought indemnity: Junior Health Minister

Bharti Pravin Pawar says Centre has set up team to deal with various issues related to procurement of Covid-19 vaccine from foreign firms

Discussing indemnity, other issues with foreign Covid vaccine makers: Govt

A team of central government officials is in continuous dialogue with foreign Covid vaccine manufactures like Pfizer, Moderna and Johnson and Johnson to discuss and address various issues

Biovac-Pfizer collaboration a breakthrough for Covid in Africa: Ramaphosa

Ramaphosa has welcomed the announcement of a collaboration between the country's Biovac Institute and US pharma giant Pfizer as a breakthrough in the protection of African nations against COVID

Small contract manufacturers wait to take a shot at Covid vaccines

A host of lesser-known vaccine makers are eyeing contract manufacturing opportunities for global and domestic majors

Pfizer to discuss Covid-19 vaccine booster with US officials today

Pfizer says it plans to meet with top US health officials Monday to discuss the drugmaker's request for federal authorization of a third dose of its Covid-19 vaccine

Pfizer Covid-19 vaccine booster dose plan sparks controversy in US

The announcement by US drugmaker Pfizer of a plan on developing a booster dose of its Covid-19 vaccine has heightened hesitancy amongst unvaccinated population and sparked confusion across country

Covid-19 pandemic: Pfizer seeks US regulator's nod for booster shot

FDA and EU regulator say no need for extra dosage at this time

Pfizer to seek US nod for third dose of Covid-19 vaccine to boost immunity

Pfizer is about to seek US authorisation for a third dose of its Covid-19 vaccine, saying Thursday that another shot within 12 months could dramatically boost immunity

4 million doses of Pfizer, Moderna likely through COVAX by August

Indemnity issue to be settled to bring the two US vaccines through COVAX

India expects 3 mn-4 mn Pfizer, Moderna vaccine doses by August: Report

'It's a donation through COVAX,' said a source

Pfizer, Moderna vaccines cut Covid-19 risk by 91 per cent: Study

The mRNA vaccines by Pfizer and Moderna contain genetic instructions for our cells to make the spike protein of the SARS-CoV-2, which the virus uses to infect and enter the human cells.

Israel to deliver 700,000 expiring doses of Pfizer vaccine to South Korea

South Korea authorized the use of Pfizer, AstraZeneca, Moderna and Janssen vaccines for people over 18.

Israel says Pfizer vaccine effectiveness against Covid-19 down to 64%

The effectiveness of the Pfizer vaccine against Covid-19 has dropped to 64 per cent in Israel, the country's Ministry of Health said.

A bottleneck in the vaccine chain

Prosenjit Datta points to a possible crisis as the government moves to improve supplies of Covid vaccines: inadequate testing facilities to handle those volumes

Pfizer, J&J vaccines more effective against Delta variant: Experts

Delta variant, first detected in India, is driving the current third wave in South Africa